Should patients with existing AF avoid GLP-1 medications
Neurodegenerative conditions, including Alzheimers disease, various forms of dementia, and Parkinsons disease, affect approximately 15% of the worldwide population, with prevalence increasing significantly with age
Both medications share some similarities and can both be effective tools for weight loss, but they are two distinct medications with some key differences
The majority of the extrahepatic tissues depend on receptor-mediated uptake of SELENOP to maintain adequate selenoprotein expression
Thats why Ive created my own Micro Dosing Protocol , which includes additional powerful antioxidants to maximize health benefits: NAD Supports cellular energy and longevity
If pharmacological intervention is needed, there are alternatives to Pepto-Bismol that may be more appropriate for specific symptoms